919 results on '"Suzuki, Tadaki"'
Search Results
2. Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc
3. Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
4. Macacine alphaherpesvirus 1 (B Virus) Infection in Humans, Japan, 2019
5. In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir
6. Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan
7. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
8. A human T-lymphotropic virus-1 carrier who developed progressive multifocal leukoencephalopathy following immunotherapy for sarcoidosis: a case report
9. Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula
10. Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2
11. Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques
12. Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2
13. Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development
14. COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study)
15. Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model
16. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate
17. Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan
18. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
19. One-dose intradermal rabies booster enhances rabies antibody production and avidity maturation
20. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
21. Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
22. Serum anti-nucleocapsid antibody level induced after primary infection is an immunological surrogate of protection against SARS-CoV-2 re-infection in hybrid immunity holders
23. A bivalent outer membrane vesicle-based intranasal vaccine to prevent infection of periodontopathic bacteria
24. Congenital Echovirus 11 Infection in a Neonate
25. Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
26. In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
27. Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection
28. High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19
29. Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
30. Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
31. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees
32. Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2
33. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
34. Characterization of a new SARS-CoV-2 variant that emerged in Brazil
35. Draft genome sequence of Yersinia pseudotuberculosis isolated from a wild rat in Japan
36. Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging
37. Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses
38. Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire
39. Mice, myeloid cells, and dengue: a new model for unraveling vascular leakage mysteries
40. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults
41. Neutrophil adhesion to vessel walls impairs pulmonary circulation in COVID-19 pathology
42. Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
43. Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
44. Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
45. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
46. COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review
47. IFN-γ‒Induced APOBEC3B Contributes to Merkel Cell Polyomavirus Genome Mutagenesis in Merkel Cell Carcinoma
48. Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants
49. Generation of JC Polyoma Pseudovirus for High-Throughput Measurement of Neutralizing Antibodies
50. Lethal severe fever with thrombocytopenia syndrome virus infection causes systemic germinal centre failure and massive T cell apoptosis in cats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.